NEO Clinic expansion in Kingston aims to meet demand for neurological services in eastern Ontario
Left to right: City of Kingston Mayor Bryan Paterson; MPP for Kingston and the Islands Ted Hsu; Dr.…
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in USSite…
Losing Weight Improves The Heartbreak Of Psoriasis For Some
For many people living with psoriasis, the red, scaly skin patches are only part of the story. Another…
Losing Weight Improves The Heartbreak Of Psoriasis For Some
For many people living with psoriasis, the red, scaly skin patches are only part of the story. Another…
FDA OKs First At-Home Brain Stim Device for Depression
The FDA has approved the first at -home brain-stimulation device for adults with major depressive disorder (MDD). The…
Genetic Testing Enables Tailored Treatments, Better Outcomes
Q: What solutions does OncoAtlas bring to patients and health professionals? A: OncoAtlas is a science-based company that…
Lessons for Parkinson’s From MS, and Vice Versa
This transcript has been edited for clarity. Indu Subramanian, MD: Hi, everyone. Welcome to Medscape. I’m so excited…
Rectal Cancer Survival Not Tied to pCR
TOPLINE: According to a meta-analysis of randomized clinical trials (RCTs), pathologic complete response (pCR) was not associated with…
MHRA Approves UK’s First Nasal Spray for Anaphylaxis
An adrenaline nasal spray for the emergency treatment of anaphylaxis has been approved by the Medicines and Healthcare…
First New PTSD Drug in Two Decades On the Horizon?
The Psychopharmacologic Drugs Advisory Committee of the FDA is set to meet on July 18 to consider a…
Is the Supplement Ready for Clinical Use?
Popular among bodybuilders, creatine supplementation is gaining traction for its potential use beyond athletic performance. Researchers are exploring…